Philips to halt CPAP sales in the U.S. as it takes $393 million provision
Published
Philips on Monday said it will halt the sales of new sleep-therapy devices in the U.S., as part of a broader settlement that led the company to take a €363 million ($393 million) provision. Philips said it will not sell any new Continuous Positive Airway Pressure or Bilevel Positive Airway…
#usjusticedepartment #usphilips #philips #ebita #phia #phg #amsterdam #citi